Rethink relief for your patients —

with ONE therapy

 

 

Magnitude of nasal symptom relief2

Nasal Symptom Reduction

Relative to fluticasone propionate and azelastine HCl comparators1,2

  1. Data shown are from study MP 4004. Across the 3 pivotal clinical trials, the improvement with Dymista ranged from 40% to 67% greater than the improvement achieved with either comparator.2

 

Select Important Safety Information

  1. Patients may experience somnolence. Caution patients against engaging in hazardous occupations requiring complete mental alertness, such as driving or operating machinery
  2. Patients should avoid concurrent use of alcohol or other central nervous system (CNS) depressants because additional reductions in alertness and additional impairment of CNS performance may occur
  3. Because of the inhibitory effect of corticosteroids on wound healing, avoid use in patients with recent nasal ulcers, nasal surgery, or nasal trauma until healed

 

Please see complete Important Safety Information below.

 

TNSS=Total Nasal Symptom Score.

*Change from baseline in the placebo-subtracted mean TNSS for each day (maximum score 24), averaged over the 14-day study period.1,2

Percent difference represents the improvement in TNSS with Dymista relative to fluticasone propionate or azelastine HCl comparator. The fluticasone propionate and azelastine HCl comparators used the same device and vehicle as Dymista and are not commercially marketed.1,2

     

Rapid Nasal Symptom Relief1

Identified by patients as one of the most important attributes of seasonal allergic rhinitis treatment3




Onset in as little as 30 minutes

Onset of action was defined as the first timepoint at which Dymista was statistically superior to placebo in the mean change from baseline in instantaneous TNSS and was sustained thereafter.1

§Change from baseline in instantaneous TNSS following administration.2

 

Select Important Safety Information

  1. Because of the inhibitory effect of corticosteroids on wound healing, avoid use in patients with recent nasal ulcers, nasal surgery, or nasal trauma until healed
  2. In clinical trials, the most common adverse reactions that occurred with Dymista Nasal Spray, azelastine HCl nasal spray, fluticasone nasal spray, and vehicle placebo groups, respectively, were dysgeusia (4%, 5%, 1%, <1%), epistaxis (2% for each group), and headache (2%, 2%, 2%, and 1%)

 

Please see complete Important Safety Information below.

     

Studies analyzed safety and tolerability in >4000 patients1

In clinical trials: In each of the 2-week pivotal trials, incidence and types of adverse reactions were comparable in all treatment groups (N=3411)

 

Safety trial: In a separate, 12-month, open-label safety trial (N=611), the overall rate of any adverse reaction was similar between treatment groups: 47% with Dymista and 44% with fluticasone propionate||

  1. Of patients treated with Dymista:
    1. None had severe epistaxis, 2% had mild epistaxis, and <1% had moderate epistaxis
    2. No nasal ulcerations or septal perforations were observed
  2. In both treatment groups, 3% of patients discontinued use because of adverse reactions

 

Select Important Safety Information

  1. Patients may experience somnolence. Caution patients against engaging in hazardous occupations requiring complete mental alertness, such as driving or operating machinery
  2. Patients should avoid concurrent use of alcohol or other central nervous system (CNS) depressants because additional reductions in alertness and additional impairment of CNS performance may occur

 

Please see complete Important Safety Information below.

The azelastine HCl and fluticasone propionate comparators used the same device and vehicle as Dymista and are not commercially marketed.1

|| As listed in the Full Prescribing Information, this trial was an open-label, active-controlled study in which 404 patients
(12 years of age and older) with chronic allergic or nonallergic vasomotor rhinitis were treated with Dymista 1 spray per nostril twice daily, and 207 patients were treated with fluticasone propionate 2 sprays per nostril once daily. 1

closeclose

Are you a healthcare professional?

closeclose All fields are required unless otherwise noted.

Sign Up

Sign up to receive Dymista news, and to be one of the first to
know when new practice tools are added to Dymista.com.

Please enter your first name

Please enter your last name

Please enter your emailPlease enter a valid email

Please confirm your emailPlease enter a valid emailPlease confirm your email

Please enter your zip code

Please choose a specialty

Please check the box if you agree to the terms of the Privacy Policy

Meda Pharmaceuticals respects your privacy—and is committed to keeping your personal information private. In order to send you additional information we will need your name, mailing address and email address. By providing this information you agree that Meda and its trusted partners may use this information to:

closeclose

Thank you

Thank you for signing up for updates from Dymista.com.
Be on the lookout for an email from us soon.

closeclose All fields are required.

Unsubscribe

Please complete the form below to stop receiving information from Dymista.

Please enter your emailPlease enter a valid email

Please confirm your emailPlease enter a valid emailPlease confirm your email

closeclose

You have been unsubscribed

You have been successfully unsubscribed from Dymista communications.

MEDA Pharmaceuticals Inc. Privacy Policy
Introduction

Thank you for your interest in MEDA Pharmaceuticals Inc. We invite you to explore our websites and learn more about us and our products. As you do so, you should know that we respect your privacy and are committed to protecting the personal information that you share with us. This Privacy Policy summarizes our standards for collecting, using, storing and sharing the personal information that we, or companies that work with us, obtain from our websites, e mail or other Web-based tools.

MEDA Pharmaceuticals Inc. is the United States subsidiary of MEDA AB, a global specialty pharmaceutical company based in Sweden and doing business in more than 41 countries around the world. This Privacy Policy applies only to MEDA Pharmaceuticals Inc., and to the MEDA product websites specifically identified as intended for use only by residents of the United States and its territories. Our Privacy Policy applies to the information that we or our trusted business partners collect from our online resources and communications like e‑mail, websites, online ordering tools and other similar content. Our Privacy Policy does not apply to third party online resources, even if our website offers courtesy links to them. We do not control the content or the privacy practices of third party resources. Read the Privacy Policy of any website or other online resource that you visit to make sure that you understand and agree with it. (That applies to our Privacy Policy too - we want you to read it carefully). If you have questions about it, or about how we protect the privacy of your personal information, you may contact us at privacy@meda.us.

We reserve the right to update or change this Privacy Policy and so, we may do that from time to time. If we do, you will be able to find those changes here. We also will tell you when the Privacy Policy was last updated or revised. This Privacy Policy was last updated on March 31, 2009.

What is - and is not - personal information? What is meant by "de-identified" information and "aggregated" information?

When we use the term "personal information", we are referring to information that can be readily used to identify a specific living person. Examples of personal information that we might wish to collect from you might include your name and your street or e‑mail address. All of those items of information can be used to identify you.

Information that relates to you, but cannot be used to identify you, is not "personal information." So, for example, your state of residence is a piece of information about you, but it is not, by itself, "personal information." However, if we collect your street address and your state of residence and we put them together in our systems, we would treat both pieces of information as "personal information" because, when taken together, they can be used to identify you.

De-identified information is information that has been stripped of features that would permit the identification of a specific living person. When de-identified information about multiple people is put together, it is referred to as "aggregated" and de-identified information. Sometimes, MEDA may choose to aggregate personal information obtained from individuals through a variety of different channels. When we do, we seek to do that in a manner consistent with this Privacy Policy and any other privacy notices that we may have provided to you.

Why does MEDA collect personal information?

We collect personal information to improve your experience as a user of our websites and also to improve others' experience as well. Sometimes the personal information that we collect enables you to use online resources or obtain communications about topics of interest to you. Personal information collected online also can help us improve our products and services, or design other features and resources that individuals would like to see us offer. We analyze the personal information that we collect so that we can identify and offer new products and services.

How do we collect personal information?

We collect personal information online through websites and other sponsored resources. Sometimes, we work with other companies that collect personal information at our request. When we work with another company, our work together is regulated by an agreement that, among other things, requires that company to properly protect the personal information it collects for us.

What tools does MEDA use to collect personal information?

Tools used from time to time to collect personal information include:

Direct Collection. In other words, we collect personal information from you by asking you to fill in an online form or participate in an interactive display. Contact details - your name, street address, e‑mail address, telephone number, birth date, etc. - are often collected directly. So is health status, so that we can provide you with information that is more likely to be relevant to you.

"Cookies". Sometimes we use cookies, and so do some of the advertisers that place advertisements on our websites. A "cookie" is a data file that a website may place on your computer hard drive. In general, cookies are used to simplify and improve your communication and interaction with a website. A website sponsor's ability to use a cookie to retrieve information from your computer can help customize the presentation of products and services, or help the website sponsor enhance their service to you.

Some cookies are temporary and erased when you leave the Internet or shut down; others stay on your computer unless or until you remove them. If you do not wish to receive cookies from MEDA websites, you can adjust your Web browser preferences on your computer. You can still visit our websites if you refuse cookies; but you may find that some of the features do not work, or do not work as well.

As a matter of policy, MEDA does not use cookies to retrieve information from your computer unless the information is related to our website or your interaction with our website.

Web Beacons. These are tiny graphics that are similar to cookies. They collect information that cannot be used to identify you personally, like the addresses of websites that you view, the website that you visited just before you came to our website, or the link that you clicked on to reach our website. Sometimes Web Beacons are used to monitor whether certain email messages are opened.

Clickstream Data. As you use the Internet, a "trail" of electronic information is left at each website you visit. This information is sometimes called "clickstream data", and it can be collected and stored by a website's server. Clickstream data is not "personal information" - it cannot be used to identify you. However, it can provide information about the type of computer and browsing software that you use, and it can identify the address of the website link that you used to reach our website. Clickstream data can be "aggregated" or combined with clickstream data from other people to anonymously determine how much time visitors spend on each page of our websites and how visitors navigate through our websites. Having this information and sharing it with business partners and advertisers can help us tailor our websites to better meet visitors' needs.

Does MEDA collect personal information from children?

In general, our websites are not directed at children and most of the online services that we offer are designed for adults, age 18 or older. Where requests for information about a medication are permitted by law, people requesting information about a medicine that is indicated for use in children must be 18 years old or older.

How does MEDA ensure that the information that we have about you is correct? Can you correct it?

Where offered, you may also update personal information about you online by modifying information that you previously entered into a Web form or data fields on our website. Otherwise, to gain access to personal information about you that we have collected online, and to keep it accurate, complete and current, you may contact us at privacy@meda.us. You may not always be able to access the information that has been collected; where permitted by law, your ability to access and correct personal information will be limited where we believe it would interfere with our ability to fulfill legal or ethical obligations or address legal claims. Access and correction also will not be allowed if it would result in disclosure of a third party's personal information, or lead to a breach of contract or disclosure of trade secrets or other protected business information.

How does MEDA store and secure personal information?

We strive to protect personal information as it is transmitted from your computer to our online resources and servers. Due to the open nature of the Internet, we cannot guarantee that our interactions with you, and yours with us, will be free from unauthorized access by third parties. We protect our servers and data with a firewall and endeavor to protect personal information in our possession, custody or control from unauthorized access, disclosure, alteration or destruction. Employees and business partners with access to your personal information must have a business-related "need to know" in order to perform their job functions for us. However, we also depend on you to help secure your information by protecting your own copies of passwords and related access codes for our online resources.

Who has access to your personal information?

Personal information about you is accessible to MEDA, including its subsidiaries, divisions and groups worldwide, and to individuals and organizations that use personal information solely for and at the direction of MEDA. Uses and disclosures of personal information by external individuals and organizations acting on MEDA's behalf are governed by agreements that require personal information to be protected appropriately. Personal information about you only will be used and disclosed by MEDA and individuals and organizations working on its behalf, in a manner consistent with this Privacy Policy, other applicable privacy notices, and as explicitly permitted or required by applicable laws, rules and regulations.

Does MEDA share your personal information with third parties?

In general, MEDA does not sell or barter your personal information to third parties. However, if MEDA decides to reorganize or divest its business through sale, merger or acquisition, it is possible that personal information may be shared with actual or prospective buyers. If that happens, MEDA will obtain a written agreement that personal information will be properly protected. Except where explicitly permitted or required by law, or provided in this Privacy Policy, personal information will not otherwise be shared without your consent.

Can you choose whether and when to share personal information with MEDA?

You do have some choices about whether and when to share personal information with MEDA.

  • If you do not want to provide any personal information to MEDA online, you can decline to enter personal information into forms or data fields on websites. You can also refuse to use personalized services offered by online resources. However, you do need to bear in mind that some online resources are only available to people who do choose to provide their personal information.
  • If you do provide some personal information online, some MEDA online resources may ask you if we can use and disclose your personal information to add you to contact lists, and to identify other services and promotions of possible interest. You can manage proposed additional uses of personal information about you by giving or withholding permission (e.g., by "checking" or "un-checking" boxes or "radio buttons" on Web forms). Also, you can change your communication preferences. For example, if you no longer wish to receive a communication, you can contact us at info@meda.us.
  • MEDA online resources use tracking technologies like cookies to remember your personal preferences and selections. Tell us if you want us to use these tools to 'remember' you and give you more services by "checking" or "un-checking" options or "radio buttons" on our Web forms, or responding to survey questions appropriately. Please note that we cannot selectively "turn on" or "turn off" certain tracking technologies like "cookies" to accommodate individual user preferences. Depending on the Web browser you use, you may be able to control the use of certain tracking technologies by adjusting your browser settings. Remember: certain features on our websites and certain online resources may work better with cookies active or enabled, so you may lose some functionality if you turn off cookies and tracking technologies.
  • If you would like to opt-out of cookies placed by business partners that deliver e mail communications for us, or place advertisements for us on other websites, please follow instructions provided by the Network Advertising Initiative at http://www.networkadvertising.org/optout_nonppii.asp
closeclose

Contact Us

DYMISTA (azelastine hydrochloride and fluticasone propionate)
is provided by Meda Pharmaceuticals, headquartered in Somerset, New Jersey.

Meda Pharmaceuticals 265 Davidson Ave. Somerset, NJ 08873-4120

 

To report side effects or product concerns, please call

(888) 939-6478

closeclose

Allergy Map

According to American Academy of Allergy, Asthma & Immunology, 35 million people in the United States suffer from allergies. Pollen from trees, grasses, and weeds typically bloom at the same time each year. That makes it easier for allergy sufferers to know when to expect their seasonal allergies to start each year.

Click the tabs to see different pollen seasons across the United States.

WEEDS

Pollen Season

  • April to Nov.
  • June to Oct.
  • July to Oct.
  • July to Nov.
Pollen Weeds Map

TREES

Pollen Season

  • Jan. to June
  • Feb. to June
  • March to June
Pollen Trees Map

GRASSES

Pollen Season

  • March to Oct.
  • April to Sept.
  • May to Aug.
Pollen Grasses Map
closeclose

Pollen Forecast

Enter your zip code and we'll give you the pollen forecast for your area.

ZIP Code

Submit
  • Today

    LOW LOW-MEDIUM MEDIUM HIGH-MEDIUM HIGH

  • LOW LOW-MEDIUM MEDIUM HIGH-MEDIUM HIGH

  • LOW LOW-MEDIUM MEDIUM HIGH-MEDIUM HIGH

  • LOW LOW-MEDIUM MEDIUM HIGH-MEDIUM HIGH

closeclose

Get the Allergy Advisor App

Get the Allergy Advisor App:

  • Get the Allergy Advisor App
  • Get the Allergy Advisor App Get the Allergy Advisor App
  • Get the Allergy Advisor App Get the Allergy Advisor App
  • Get the Allergy Advisor App
  • Get the Allergy Advisor App

Get the Allergy Advisor App

Get the Allergy Advisor App

Available in android market Available in the app store